BUSINESS● LOW1h ago · Oct 29, 2026, 6:32 AM
Bausch Health signals 2026 revenue of $5.525B-$5.625B as it outlines Q4 Xifaxan headwinds
Seeking Alpha Tech · global
Bausch Health has provided revenue forecasts for 2026, anticipating $5.525B-$5.625B, while also discussing challenges for its Q4 Xifaxan product. This information is relevant for investors and market analysis.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowGold in Ghana: After Damang, is Gold Fields at risk of being ousted from the Tarkwa mine?Jeune AfriqueBUSINESS20m agoBroadstone Net Lease declares $0.2925 dividendSeeking Alpha Tech